Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.9% Passive Stake in MacroGenics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.9% beneficial ownership stake in MacroGenics Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Manhattan Associates, Disclosing 10.2% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 22 to Schedule 13G, reporting a 10.2% beneficial ownership stake in Manhattan Associates Inc., totaling 6,182,552 common shares.
NYSE
BlackRock, Inc. has filed an Amendment No. 18 to Schedule 13G, disclosing a 13.3% beneficial ownership stake in Mercury Systems Inc. common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a 6.2% beneficial ownership stake in Motorcar Parts America Inc., holding 1,208,730 common shares as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.7% of New Fortress Energy Inc.'s Class A Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a 5.0% beneficial ownership stake in Idaho Strategic Resources, Inc., holding 704,941 shares of common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in New York Mortgage Trust to 15.3%
BlackRock, Inc. has disclosed an increased beneficial ownership of 15.3% in New York Mortgage Trust Inc.'s common stock, holding over 13.8 million shares.
NYSE
BlackRock, Inc. has reported a significant beneficial ownership stake of 5.3% in Oruka Therapeutics, Inc., totaling 1,988,880 shares of common stock.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.5% Stake in Outset Medical
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in medical technology company Outset Medical, Inc. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.9% Passive Stake in Ovid Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.9% passive beneficial ownership stake in Ovid Therapeutics Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in PVH Corp. as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Stake in Progressive Corp
BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, disclosing a beneficial ownership of 7.2% in Progressive Corp's common stock as of June 30, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.0% Stake in Tango Therapeutics
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Tango Therapeutics, Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.3% Stake in Jade Biosciences
BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 5.3% of Jade Biosciences, Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.4% Stake in Calumet, Inc.
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Calumet, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.4% of Ford Motor Company's common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.9% Passive Stake in Sandisk Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.9% beneficial ownership stake in Sandisk Corp's common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14% Stake in SITE Centers Corp.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.0% beneficial ownership stake in SITE Centers Corp. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a 5.7% beneficial ownership stake in Sky Harbour Group Corporation's Class A Stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in Skyworks Solutions to 11.2%
BlackRock, Inc. has reported an increased beneficial ownership of 11.2% in Skyworks Solutions Inc., holding over 16.8 million shares of common stock.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a 7.5% beneficial ownership stake in SmartStop Self Storage REIT, Inc.'s common stock.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a 7.8% beneficial ownership stake in Spectrum Brands Holdings Inc.'s common stock.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a 5.0% beneficial ownership stake in Summit Midstream Corp's Common Stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.4% Stake in Talos Energy Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.4% beneficial ownership stake in Talos Energy Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 8.6% in ULTA BEAUTY INC common stock as of June 30, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.1% Stake in Xponential Fitness
BlackRock, Inc. has reported a beneficial ownership of 5.1% of Xponential Fitness, Inc.'s Class A Stock, totaling 1,779,376 shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.5% beneficial ownership stake in ExlService Holdings, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 5.5% of Faraday Future Intelligent Electric Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.4% Stake in Ferguson Enterprises
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Ferguson Enterprises Inc.'s common stock as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.0% Stake in FibroBiologics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.0% beneficial ownership stake in FibroBiologics, Inc. as of June 30, 2025.